Posted inMarket
H.C. Wainwright Reaffirms Buy Rating for Milestone Pharmaceuticals Following Regulatory Nod in China
H.C. Wainwright maintains its Buy rating for Milestone Pharmaceuticals following a significant regulatory approval in China.
Posted inMarket
Why Stock Market Selloff Risks Are Growing and How Investors Should Respond
Discover why financial experts warn that stock market selloff risks are increasing and learn strategic steps to protect your investment portfolio today.
Posted inMarket
Why Government Market Interventions Are Alarming Global Investors
Discover why recent government market interventions like bond buybacks and currency buying are causing deep concern among global investors today.
Posted inEmerging Market
Tata Chemicals Kenya Exit: Understanding the Magadi Dispute and Presidential Directive
Explore the reasons behind President Ruto's directive for Tata Chemicals to exit Kenya, focusing on local value creation and the company's response.
Posted inMarket
Trading Strategy for Midterm Election Market Volatility
Discover how professional traders protect portfolios against potential market chaos and disputes during midterm elections using simple portfolio insurance.
Posted inEmerging Market
Delhi NCR Heavy Rains Trigger Red Alert and Flight Disruptions at IGI Airport
Delhi NCR faces heavy rainfall and a red alert from IMD. Flight operations at IGI airport are severely affected with major delays from multiple cities.
Posted inBusiness Insights
Global Billionaire Wealth Surges to Record High of 15.1 Trillion Dollars
Discover how the total wealth of the world's billionaires reached a historic 15.1 trillion dollars last year, according to a comprehensive new global report.
Posted inMarket
Baird Raises DocuSign Stock Price Target Following Strong ARR Growth
Financial firm Baird has increased DocuSign stock price target to $72 following solid annual recurring revenue growth.
Posted inMarket
Freedom Broker Downgrades Vale Stock to Sell Amid Growth Concerns
Freedom Broker downgrades Vale stock rating to sell, citing high growth concentration risks and market challenges facing the mining giant.
Posted inMarket
Freeport-McMoRan Stock Upgraded by Freedom Broker Following Mine Recovery
Freedom Broker upgrades Freeport-McMoRan stock rating following the successful recovery of mining operations and steady market demand.
